Form D Explorer
TriSalus Life Sciences, Inc. · CIK 1826667

Report a data issueCitable research briefCompare issuerPrivate research collection

TriSalus Life Sciences, Inc.

CIK 1826667 · Corporation · Inc. DELAWARE · WESTMINSTER, Colorado · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
1
Original notices
1
Amendments
0
Activity
May 8, 2025
through May 8, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · May 8, 2025

Reported offering amount
$22,000,000
Reported exemptions
Rule 506(b)
Reported amount sold
$22,000,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Form D filings (1)